Health Trials

Osteochondritis Dissecans (OCD)

2

Review clinical trials related to Osteochondritis Dissecans (OCD). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee

The objective of this study is to compare the efficacy and safety of MACI® vs arthroscopic microfracture in the treatment of participants aged 10 to 17 years with symptomatic articular chondral or osteochondral defects of the knee.

Participants needed: 45
Trial details
Phase: Phase 3Age: 10-17Biological sex: AllType: InterventionalSponsor: Vericel CorporationUpdated: Jun 24, 2026Locations: 12
Eligibility criteria

Symptomatic cartilage or osteochondral defects [+3]

At least 1 defect size ≥1.5 cm2 on the patella, femoral condyles and/or the troc... [+21]

Read more
Status: Not yet recruiting

MaioRegen Prime Study for the Treatment of Deep Osteochondral Lesion of the Knee

The present study aims to compare the efficacy and the safety of MaioRegen Prime to Debridement (SSOC) in patients with deep osteochondral lesions of the knee joint. The foreseen population involves patients with osteochondral lesions with different etiology, dimension, shape, and location. The evaluation will be performed through clinical, subjective and objective assessments.

Participants needed: 400
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: Fin-Ceramica Faenza SpaUpdated: Jan 12, 2026
Eligibility criteria

Informed consent prior to any study-related procedures; [+8]

IKDC subjective score at Baseline is more than or equal to 70; [+29]

Read more